Ana Lisa Basquiera (@basquiera) profile picture

Médica Hematóloga. Hospital Privado Universitario de Cordoba. IUCBC. @SAHematologia #BMT #CART #quality #cellulartherapy

Joined April 2019
Photo by Ana Lisa Basquiera (@basquiera)Photo by Ana Lisa Basquiera (@basquiera)Photo by Ana Lisa Basquiera (@basquiera)Photo by Ana Lisa Basquiera (@basquiera)Photo by Ana Lisa Basquiera (@basquiera)Photo by Ana Lisa Basquiera (@basquiera)Photo by Ana Lisa Basquiera (@basquiera)Photo by Ana Lisa Basquiera (@basquiera)Photo by Ana Lisa Basquiera (@basquiera)Photo by Ana Lisa Basquiera (@basquiera)
Ana Lisa Basquiera retweeted
What is the right duration of antibiotic therapy after hematopoietic cell transplantation? In this expert discussion, Diego R. Hijano, MD, MSc, Gabriela Marón, MD, MSc, and Fareed Khawaja, MBBS, review emerging clinical evidence, evolving guidelines, and future research directions surrounding antibiotic de-escalation in transplant recipients. Tune in: ow.ly/HgZe5101mH2
4
7
992
Ana Lisa Basquiera retweeted
Un placer compartir con el Dr. Caeiro y la Dra. Clavijo un simposio sobre la primera recaída en mieloma múltiple. 🔬 MajesTEC-3: dara+ tec abre nuevas perspectivas. Un cambio de paradigma: del control de la enfermedad hacia la cura funcional y, eventualmente, tratamientos finitos
4
9
177
Desde julio iniciamos en @hcmquintela el tratamiento con células CART anti CD19 en el contexto del ensayo clínico liderado por @perezscremini Estamos orgullosos de poder hacer llegar a los pacientes adultos este tratamiento desde el Hospital Universitario @fmedoficial @Udelaruy
12
2
51
2,019
Ana Lisa Basquiera retweeted
What happens in the bone marrow clonal dynamics during sepsis? We studied by looking at emergency hematopoiesis in the ICU setting 👇@ClevelandClinic @Yale #CHIP @aamdsif @MDSFoundation @olisaogbue
2
17
1
54
2,873
En el mes de setiembre la Unidad Académica de Hematología @CatedraHemato realizó el 1er Trasplante Autólogo de Progenitores Hematopoyéticos en @hcmquintela en el marco del subprograma de TPH con @ASSEHMaciel @FNR_Uruguay Destacamos la importancia del trabajo interdisciplinario
11
2
68
3,129
Ana Lisa Basquiera retweeted
Daratumumab in immune-mediated thrombotic thrombocytopenic purpura: emerging evidence for plasma cell–targeted therapy tandfonline.com/doi/full/10.…
2
9
2
39
2,479
Ana Lisa Basquiera retweeted
Relapse is a challenge after allogeneic transplantation in FLT3-ITD AML. A large German registry study examines FLT3 inhibitor maintenance after transplant, highlighting real-world outcomes with sorafenib and other FLT3 inhibitors. doi.org/10.3324/haematol.202…
11
1
50
2,566
Ana Lisa Basquiera retweeted
Teclistamab densitization of donor-specific antibodies in aplastic anemia before haploHCT Spoiler alert: it works, and yes, lower doses were used 😉 Our paper is out in Early View | @Haematologica haematologica.org/newsletter…
1
18
1
73
3,533
This study found that ≥10% FEV1 decline affected ~48% of #alloHSCT recipients and was the strongest predictor of post-transplant mortality. Mortality risk remained elevated even after FEV1 recovery. Read: astctjournal.org/article/S26…
4
8
662
Ana Lisa Basquiera retweeted
Proud to see @AnnaSureda5 on stage at #ISHL 2026 in Cologne, Germany 🇩🇪. The only Spaniard 🇪🇸 presenting in the International Symposium on Hodgkin Lymphoma #lymsm @sehh_es @geltamo
6
1
38
1,013
Ana Lisa Basquiera retweeted
Join ASTCT on Oct. 15 for an in-depth discussion on transplant considerations and emerging approaches for older patients with TP53-mutated disease. Register:
1
2
458
Ana Lisa Basquiera retweeted
📊 New Infographic on ASTCT Nucleus: Geriatric assessment can help identify patient vulnerabilities, predict outcomes, and guide personalized care for older adults undergoing transplantation and cellular therapy. Explore key insights, implementation strategies, and expert recommendations for integrating geriatric assessment into clinical practice. 🔗 astct.org/Nucleus/Article/in…
2
4
461
Ana Lisa Basquiera retweeted
Laura donó células para salvar la vida de otra persona en el mundo 🌎 El Día Mundial del Donante de Médula Ósea se celebra cada año con el objetivo de agradecer a los donantes. Es una oportunidad para crear conciencia sobre la importancia de inscribirse en el Registro Nacional de Donantes de Células Progenitoras Hematopoyéticas (CPH). El Registro argentino forma parte de la World Marrow Donor Association (WMDA), una red conformada por los Registros de 63 países. Así, una persona que necesita un trasplante puede encontrar un donante compatible sin importar dónde se encuentre.  ¿Querés ser parte de la red? El primer paso es inscribirse 💛 Si tenés entre 18 y 40 años y gozás de buena salud, podés hacerlo donando sangre (tenés que pesar más de 50kg) o con un hisopado bucal ✅ Encontrá los centros habilitados 👉🏻 argentina.gob.ar/salud/mapam… #DonáCélulas #WMDD
11
2
15
1,042
Ana Lisa Basquiera retweeted
Yi Lin, MD, PhD, describes the science behind a phase 1 study of anitocabtagene autoleucel, a CAR T cell that deploys a CAR with a novel synthetic antigen-binding domain, in patients with multiple myeloma. Learn more about the science behind the study in the editorial “Anito-cel for Multiple Myeloma”: nej.md/4hF5Gxj
1
51
149
22,794
Proud to share our latest publication from the Argentine GATMO-TC network @SAHematologia on allogeneic transplantation for Chronic Myeloid Leukemia in the TKI era. 🇦🇷 rdcu.be/BqEwdfFxiHWa @SpringerNature #CML #AlloHCT #BloodCancer #BMT #Hematology
2
14
501
Ana Lisa Basquiera retweeted
Among children with high-risk B-cell acute lymphoblastic leukemia, two cycles of blinatumomab led to a higher 4-year event-free survival than two cycles of chemotherapy (83.0% vs. 70.3%), with a lower risk of serious infection. Full phase 3 AIEOP-BFM ALL 2017 trial results: nej.md/4dBfwOk Editorial: Blinatumomab — A New Standard of Care in Acute Lymphoblastic Leukemia nej.md/3UWmKWP
1
53
9
164
31,002